These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece. Pliaka V, Ruether IG, Kyriakopoulou Z, Kioussi P, Plakokefalos E, Megalou M, Pratti A, Levidiotou-Stefanou S, Markoulatos P. Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919 [Abstract] [Full Text] [Related]
4. Approaches to the construction of new candidate poliovirus type 3 vaccine strains. Almond JW, Stone D, Burke K, Skinner MA, Macadam AJ, Wood D, Ferguson M, Minor PD. Dev Biol Stand; 1993 Nov; 78():161-9; discussion 169-70. PubMed ID: 8388827 [Abstract] [Full Text] [Related]
6. Long-term excretion of vaccine-derived poliovirus by a healthy child. Martín J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD. J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492 [Abstract] [Full Text] [Related]
7. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. Martín J, Samoilovich E, Dunn G, Lackenby A, Feldman E, Heath A, Svirchevskaya E, Cooper G, Yermalovich M, Minor PD. J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335 [Abstract] [Full Text] [Related]
8. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. Blomqvist S, Bruu AL, Stenvik M, Hovi T. J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808 [Abstract] [Full Text] [Related]
9. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM. J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [Abstract] [Full Text] [Related]
11. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures. Crainic R, Blondel B, Candréa A, Dufraisse G, Horaud F. Dev Biol Stand; 1985 Dec; 60():343-7. PubMed ID: 2995173 [Abstract] [Full Text] [Related]
13. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Iwai M, Takizawa T, Nakayama T, Matsuura K, Yoshida H, Hasegawa S, Obara M, Horimoto E, Kurata T, Horie H. Scand J Infect Dis; 2008 Dec; 40(3):247-53. PubMed ID: 17907043 [Abstract] [Full Text] [Related]
15. A Sabin 2-related poliovirus recombinant contains a homologous sequence of human enterovirus species C in the viral polymerase coding region. Zhang Y, Zhang F, Zhu S, Chen L, Yan D, Wang D, Tang R, Zhu H, Hou X, An H, Zhang H, Xu W. Arch Virol; 2010 Feb; 155(2):197-205. PubMed ID: 19946714 [Abstract] [Full Text] [Related]
16. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Richardson G, Linkins RW, Eames MA, Wood DJ, Campbell PJ, Ankers E, Deniel M, Kabbaj A, Magrath DI, Minor PD. Bull World Health Organ; 1995 Feb; 73(6):769-77. PubMed ID: 8907770 [Abstract] [Full Text] [Related]
17. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. Shulman LM, Manor Y, Sofer D, Handsher R, Swartz T, Delpeyroux F, Mendelson E. PLoS One; 2006 Dec 20; 1(1):e69. PubMed ID: 17183700 [Abstract] [Full Text] [Related]
18. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Friedrich F. Acta Virol; 1996 Jun 20; 40(3):157-70. PubMed ID: 8891097 [Abstract] [Full Text] [Related]
19. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda. Mugisha L, Pauli G, Opuda-Asibo J, Joseph OO, Leendertz FH, Diedrich S. J Med Primatol; 2010 Apr 20; 39(2):123-8. PubMed ID: 20102460 [Abstract] [Full Text] [Related]
20. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany. Eggers M, Terletskaia-Ladwig E, Rabenau HF, Doerr HW, Diedrich S, Enders G, Enders M. BMC Infect Dis; 2010 Dec 09; 10():347. PubMed ID: 21143885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]